Jan 2, 2021 | Computational methods for biomarker discovery
Sponsor: NIH Cognitive decline due to Alzheimer’s disease (AD) is closely associated with brain structure alterations captured by structural magnetic resonance imaging (sMRI). It supports the validity to develop sMRI-based univariate neurodegeneration biomarkers...
Jan 2, 2021 | Computational methods for biomarker discovery
Sponsors: NIH, AZ Alzheimer Consortium Biomarker assisted preclinical/early detection and intervention in Alzheimer’s disease (AD) may be the key to therapeutic breakthroughs. One of the presymptomatic hallmarks of AD is the accumulation of beta-amyloid (Aβ) plaques...
Oct 21, 2020 | AI in medicine and imaging
Sponsor NSF A significant challenge in treating some aggressive cancers and neurological diseases is the lack of understanding regarding the spatial-temporal molecular heterogeneity of the diseased tissue/organ. Molecular characteristics and interaction vary...
Oct 21, 2020 | AI in medicine and imaging
Sponsor: Amgen Inc. This study will investigate longitudinal changes in brain structure and function in high frequency episodic and chronic migraine patients who are responding to erenumab treatment compared to those patients who are non-responders. In addition,...
Oct 21, 2020 | AI in medicine and imaging
Sponsor: DOD The broad, long-term goal of this multi-disciplinary collaborative of biomedical engineers and physician- scientists is to develop early, non-invasive methods to identify individuals at risk of developing chronic kidney disease (CKD). Current methods to...